|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.42 CAD | -2.33% |
|
-2.33% | -14.29% |
| May. 08 | Crescita Therapeutics Q1 Loss Widens, Revenue Rises | MT |
| May. 08 | Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million | MT |
Crescita Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CAD 5 million compared to CAD 4.6 million a year ago. Net loss was CAD 0.626 million compared to CAD 0.273 million a year ago.
Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.03 compared to CAD 0.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.29% | 5.98M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
CRESCITA THERAPEUTICS INC. 
